Clinical Trials Logo
NCT number NCT03180879
Study type Interventional
Source Reckitt Benckiser Healthcare (UK) Limited
Contact
Status Active, not recruiting
Phase Phase 1
Start date April 10, 2017
Completion date July 3, 2017

Clinical Trial Summary

This project is the in-house development of a 200 mg ibuprofen acid orodispersable tablet (ODT; meltlet). It is designed to appeal to consumers who want a dosage form that may be taken without water and can be used 'on the go'. Vanquish has an improved organoleptic profile compared to the currently marketed meltet by the Sponsor. ODTs are also considered as a suitable dosage form for children who may be reluctant to swallow tablets. This product has the potential for application in both adults and children due to the convenience of the format and the ease of administration for both groups.

This will be the first pharmacokinetic (PK) assessment of the ibuprofen acid ODT formulation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


See also
Status Clinical Trial Phase
 Terminated NCT00001844 - Study of New Magnetic Resonance Methods N/A
 Completed NCT02235961 - Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects Phase 1
 Completed NCT00526916 - PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28 Phase 1
 Completed NCT00527579 - PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB Phase 1
 Recruiting NCT02509494 - Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo During Implementation of Stages 1 and 2 Phase 3
 Terminated NCT02555085 - Single Ascending Doses of BIIB063 in Healthy Volunteers Phase 1
 Completed NCT03125018 - Accuracy of SpO2 for Noninvasive Pulse Oximeter Sensor (LNCS ADTX) N/A
 Completed NCT03124901 - Accuracy of Noninvasive Pulse Oximeter Measurement of Hemoglobin for Rainbow DCI Sensor N/A
 Completed NCT00091533 - Neural Correlates of Observation of Tactile Stimulation in Healthy Subjects N/A
 Completed NCT00068926 - VRC 300: Screening of Healthy Volunteers for Clinical Trials of Investigational Vaccines to Prevent Infectious Diseases N/A
 Completed NCT02947139 - Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20161 in Healthy Volunteers Phase 1
 Completed NCT00538798 - PET Imaging of Brain mGluR5 Receptors Using [18F]SP203 Phase 1
 Completed NCT00097461 - Revising Employee Benefits for the Sake of Health N/A
 Completed NCT00001936 - Electrical Muscle Stimulation to Aid Swallowing in Dysphagia N/A
 Completed NCT00004556 - The Effects of Dextroamphetamine on Brain Function N/A
 Recruiting NCT03119909 - Cognitive Adaptation N/A
 Completed NCT03179345 - Simulated Driving Performance, Daytime Sedation and Cognition in Healthy Volunteers Taking Gralise, Neurontin or Lyrica Phase 4
 Completed NCT02911870 - A Thorough QTc Trial Evaluating the Effect of SNAC on Cardiac Repolarisation in Healthy Male Subjects Phase 1
 Completed NCT03056898 - Health Professional Dietary Habits and Blood Omega-3 Fatty Acid Concentrations N/A
 Completed NCT02543567 - A Study to Evaluate A Range of Dose Levels of Ad26.ZEBOV and MVA‐BN‐Filo in Healthy Adult Participants Phase 3